AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus
Authors: Ukkola, O Erkkila, PH Savolainen, MJ Kesaniemi, YA
Citation: O. Ukkola et al., Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus, J INTERN M, 249(5), 2001, pp. 451-459
Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism
Authors: Karjalainen, A Paassilta, M Heikkinen, J Backstrom, AC Savolainen, M Kesaniemi, YA
Citation: A. Karjalainen et al., Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism, CLIN ENDOCR, 54(2), 2001, pp. 165-173
Dose-response issues concerning physical activity and health: an evidence-based symposium
Authors: Kesaniemi, YA Danforth, E Jensen, MD Kopelman, PG Lefebvre, P Reeder, BA
Citation: Ya. Kesaniemi et al., Dose-response issues concerning physical activity and health: an evidence-based symposium, MED SCI SPT, 33(6), 2001, pp. S351-S358
Weight loss reduces expression of SREBP1c/ADD1 and PPAR gamma 2 in adiposetissue of obese women
Authors: Ribot, J Rantala, M Kesaniemi, YA Palou, A Savolainen, MJ
Citation: J. Ribot et al., Weight loss reduces expression of SREBP1c/ADD1 and PPAR gamma 2 in adiposetissue of obese women, PFLUG ARCH, 441(4), 2001, pp. 498-505
APOE-epsilon 4 is associated with weight loss in women with AD - A population-based study
Authors: Vanhanen, M Kivipelto, M Koivisto, K Kuusisto, J Mykkanen, L Helkala, EL Hanninen, T Kervinen, K Kesaniemi, YA Laakso, MP Soininen, H Laakso, M
Citation: M. Vanhanen et al., APOE-epsilon 4 is associated with weight loss in women with AD - A population-based study, NEUROLOGY, 56(5), 2001, pp. 655-659
Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women
Authors: Silaste, ML Rantala, M Sampi, M Alfthan, G Aro, A Kesaniemi, YA
Citation: Ml. Silaste et al., Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women, J NUTR, 131(10), 2001, pp. 2643-2647
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment
Authors: Karpe, F Taskinen, MR Nieminen, MS Frick, MH Kesaniemi, YA Pasternack, A Hamsten, A Syvanne, M
Citation: F. Karpe et al., Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment, ATHEROSCLER, 157(1), 2001, pp. 181-187
Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness
Authors: Kakko, S Tamminen, M Paivansalo, M Kauma, H Rantala, AO Lilja, M Reunanen, A Kesaniemi, YA Savolainen, MJ
Citation: S. Kakko et al., Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness, EUR J CL IN, 31(7), 2001, pp. 593-602
Mechanisms regulating LDL metabolism in subjects on peroral and transdermal estrogen replacement therapy
Authors: Karjalainen, A Heikkinen, J Savolainen, MJ Backstrom, AC Kesaniemi, YA
Citation: A. Karjalainen et al., Mechanisms regulating LDL metabolism in subjects on peroral and transdermal estrogen replacement therapy, ART THROM V, 20(4), 2000, pp. 1101-1106
Low-density lipoprotein particle composition: what is the contribution to atherogenicity?
Authors: Rudel, LL Kesaniemi, YA
Citation: Ll. Rudel et Ya. Kesaniemi, Low-density lipoprotein particle composition: what is the contribution to atherogenicity?, CURR OP LIP, 11(3), 2000, pp. 227-228
Gamma-glutamyl transpeptidase and the metabolic syndrome
Authors: Rantala, AO Lilja, M Kauma, H Savolainen, MJ Reunanen, A Kesaniemi, YA
Citation: Ao. Rantala et al., Gamma-glutamyl transpeptidase and the metabolic syndrome, J INTERN M, 248(3), 2000, pp. 230-238
Dietary and other non-pharmacological treatments in patients with drug-treated hypertension and control subjects
Authors: Silaste, ML Junes, R Rantala, AO Kauma, H Lilja, M Savolainen, MJ Reunanen, A Kesaniemi, YA
Citation: Ml. Silaste et al., Dietary and other non-pharmacological treatments in patients with drug-treated hypertension and control subjects, J INTERN M, 247(3), 2000, pp. 318-324
Baroreflex sensitivity and variants of the renin angiotensin system genes
Authors: Ylitalo, A Airaksinen, KEJ Hautanen, A Kupari, M Carson, M Virolainen, J Savolainen, M Kauma, H Kesaniemi, YA White, PC Huikuri, HV
Citation: A. Ylitalo et al., Baroreflex sensitivity and variants of the renin angiotensin system genes, J AM COL C, 35(1), 2000, pp. 194-200
Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: A population-based longitudinal study
Authors: Koivisto, AM Lempiainen, P Koivisto, K Helkala, EL Mykkanen, L Kuusisto, J Kervinen, K Kesaniemi, YA Laakso, M Soininen, H
Citation: Am. Koivisto et al., Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: A population-based longitudinal study, NEUROEPIDEM, 19(6), 2000, pp. 327-332
Apolipoprotein E phenotype, cholesterol and breast and prostate cancer
Authors: Niemi, M Kervinen, K Kiviniemi, H Lukkarinen, O Kyllonen, AP Apaja-Sarkkinen, M Savolainen, MJ Kairaluoma, MI Kesaniemi, YA
Citation: M. Niemi et al., Apolipoprotein E phenotype, cholesterol and breast and prostate cancer, J EPIDEM C, 54(12), 2000, pp. 938-939
Regulation of plasma low density lipoprotein levels in postmenopausal women
Authors: Karjalainen, A Heikkinen, J Savolainen, MJ Backstrom, AC Kesaniemi, YA
Citation: A. Karjalainen et al., Regulation of plasma low density lipoprotein levels in postmenopausal women, ATHEROSCLER, 151(2), 2000, pp. 559-566
Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a)levels
Authors: Paassilta, M Karjalainen, A Kervinen, K Savolainen, MJ Heikkinen, J Backstrom, AC Kesaniemi, YA
Citation: M. Paassilta et al., Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a)levels, ATHEROSCLER, 149(1), 2000, pp. 157-162
Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men
Authors: Kakko, S Tamminen, M Paivansalo, M Kauma, H Rantala, AO Lilja, M Reunanen, A Kesaniemi, YA Savolainen, MJ
Citation: S. Kakko et al., Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men, EUR J CL IN, 30(1), 2000, pp. 18-25
The apolipoprotein epsilon 4 allele determines prognosis and the effect onprognosis of simvastatin in survivors of myocardial infarction - A substudy of the Scandinavian Simvastatin Survival Study
Authors: Gerdes, LU Gerdes, C Kervinen, K Savolainen, M Klausen, IC Hansen, PS Kesaniemi, YA Faergeman, O
Citation: Lu. Gerdes et al., The apolipoprotein epsilon 4 allele determines prognosis and the effect onprognosis of simvastatin in survivors of myocardial infarction - A substudy of the Scandinavian Simvastatin Survival Study, CIRCULATION, 101(12), 2000, pp. 1366-1371
Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of therole of genetic variation in responsiveness to diet
Authors: Rantala, M Rantala, TT Savolainen, MJ Friedlander, Y Kesaniemi, YA
Citation: M. Rantala et al., Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of therole of genetic variation in responsiveness to diet, AM J CLIN N, 71(3), 2000, pp. 713-724
Prevalence of the metabolic syndrome in drug-treated hypertensive patientsand control subjects
Authors: Rantala, AO Kauma, H Lilja, M Savolainen, MJ Reunanen, A Kesaniemi, YA
Citation: Ao. Rantala et al., Prevalence of the metabolic syndrome in drug-treated hypertensive patientsand control subjects, J INTERN M, 245(2), 1999, pp. 163-174
Apolipoprotein E, alcohol, and blood pressure: Reply to Puddey et al
Authors: Kauma, H Savolainen, MJ Kesaniemi, YA
Citation: H. Kauma et al., Apolipoprotein E, alcohol, and blood pressure: Reply to Puddey et al, AM J HYPERT, 12(9), 1999, pp. 949-950
Glucose metabolism, insulin-like growth factor-I, and insulin-like growth factor-binding protein-1 after alcohol withdrawal
Authors: Paassilta, M Kervinen, K Kesaniemi, YA
Citation: M. Paassilta et al., Glucose metabolism, insulin-like growth factor-I, and insulin-like growth factor-binding protein-1 after alcohol withdrawal, ALC CLIN EX, 23(3), 1999, pp. 471-475
The effect of the apolipoprotein E phenotype on cholesteryl ester transferprotein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment
Authors: Korhonen, T Hannuksela, ML Seppanen, S Kervinen, K Kesaniemi, YA Savolainen, MJ
Citation: T. Korhonen et al., The effect of the apolipoprotein E phenotype on cholesteryl ester transferprotein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment, EUR J CL PH, 54(12), 1999, pp. 903-910
Variation of apolipoprotein B as a possible cause of decreased low densitylipoprotein clearance and hypercholesterolemia
Authors: Korhonen, T Savolainen, MJ Kesaniemi, YA
Citation: T. Korhonen et al., Variation of apolipoprotein B as a possible cause of decreased low densitylipoprotein clearance and hypercholesterolemia, ATHEROSCLER, 146(1), 1999, pp. 1-10
Risultati: 1-25 | 26-29